The Discounted Cash Flow (DCF) valuation of Redhill Biopharma Ltd (RDHL) is (11,525.77) USD. With the latest stock price at 0.80 USD, the upside of Redhill Biopharma Ltd based on DCF is -1441903.0%.
Based on the latest price of 0.80 USD and our DCF valuation, Redhill Biopharma Ltd (RDHL) is a sell. selling RDHL stocks now will result in a potential gain of 1441903.0%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 5.8% - 8.7% | 7.3% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (46,119.14) - (6,601.23) | (11,525.77) |
| Upside | -5769319.5% - -825873.2% | -1441903.0% |